Halyard Health (NYSE: HYH) and Great Basin Scientific (NASDAQ:GBSN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.
Analyst Ratings
This is a summary of recent ratings for Halyard Health and Great Basin Scientific, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Halyard Health | 0 | 1 | 3 | 0 | 2.75 |
| Great Basin Scientific | 0 | 0 | 0 | 0 | N/A |
Halyard Health currently has a consensus price target of $41.67, indicating a potential downside of 4.30%. Given Halyard Health’s higher possible upside, research analysts plainly believe Halyard Health is more favorable than Great Basin Scientific.
Earnings & Valuation
This table compares Halyard Health and Great Basin Scientific’s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| Halyard Health | $1.60 billion | 1.27 | $182.00 million | $1.03 | 42.27 |
| Great Basin Scientific | $3.15 million | 0.04 | -$30.80 million | N/A | N/A |
Halyard Health has higher revenue and earnings than Great Basin Scientific.
Volatility & Risk
Halyard Health has a beta of 1.78, suggesting that its stock price is 78% more volatile than the S&P 500. Comparatively, Great Basin Scientific has a beta of 5.09, suggesting that its stock price is 409% more volatile than the S&P 500.
Institutional & Insider Ownership
90.3% of Halyard Health shares are owned by institutional investors. 1.3% of Halyard Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares Halyard Health and Great Basin Scientific’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Halyard Health | 3.06% | 8.29% | 4.44% |
| Great Basin Scientific | 2,588.36% | N/A | 168.06% |
Summary
Halyard Health beats Great Basin Scientific on 8 of the 11 factors compared between the two stocks.
About Halyard Health
Halyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. The Company address healthcare needs, such as reducing the use of opioids, while helping patients move from surgery to recovery. The Medical Devices segment’s products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes. The S&IP segment includes product offerings, such as sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.
About Great Basin Scientific
Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C. diff) and Group B Strep. Its system includes an analyzer and a diagnostic cartridge. Each analyzer contains a module into, which individual test cartridges are placed. Its other diagnostic assays in the late stages of product development include a pre-surgical nasal screen for Staphylococcus aureus (SA), food borne pathogen panel, panel for candida blood infections, test for pertussis and a test for Chlamydia tracomatis (CT)/Neisseria gonorrhea (NG). The Company also has a pipeline of assays in an early stage of development, including respiratory testing and sepsis (blood infection) panels. It markets a platform of molecular testing in small to medium sized hospitals.
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
